DOI : 10.1055/s-00000034

Klinische Pädiatrie

Ausgabe 03 · Volume 229 · Mai 2017 DOI: 10.1055/s-007-33986

Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung
30. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung
Wilsede, Lüneburger Heide, 07.06 – 10.06.2017

Wissenschaftliche Leitung: Prof. Dr. Martin Horstmann Prof. Dr. Martin Stanulla Prof. Dr. Rolf Marschalek Prof. Dr. Olaf Heidenreich
Abstracts (HTML) Autorenliste
A1
Alejo, O; Emmrich, S; Heckl, D; Klusmann, JH: Members of the miR-99/100˜125 tricistrons cooperatively induce a pre-leukemic phenotype
A2
Alhammer, A; Case, M; Blair, HJ; Vormoor, J; Irving, J: Exploring Pre-B Cell Receptor Signalling as a Therapeutic Target in Acute Lymphoblastic Leukaemia
A3
Heckl, BC; Carlet, M; Grunert, M; Vick, B; Marschalek, R; Schewe, D; Spiekermann, K; Hiddemann, W; Jeremias, I: Genetic characteristics determine lentiviral transduction rates in patient-derived ALL cells
A4
Meyer, C; Marschalek, R: The MLL recombinome 2017
A5
Mangolini, M; Gasparoli, L; Virely, C; Edwards, D; Bartram, J; Goulden, N; Ancliff, P; de Boer, J; Williams, O: Targeting ARHGEF4 in cancer
A6
Armenteros-Monterroso, E; Zhao, L; de Boer, J; Williams, O: Investigating Reptin function in Acute Myeloid Leukaemia
A7
Strüwe, FJ; Stachorsky, L; Thangapandi, R; Gialesaki, S; Knoess, S; Heckl, D; Klusmann, JH: Deconvoluting the oncogenic interactome in Transient Abnormal Myelopoiesis (TAM)
A8
Zinngrebe, J; Meyer, M; Debatin, KM; Meyer, LH: Targeting IAPs in childhood ALL – a promising therapeutic option?
A9
Beckett, M; Krippner-Heidenreich, A; van Delft, F: In vitro and in vivo whole genome CRISPR screening under drug treatment in T-ALL
A10
Martinez-Soria, N; McKenzie, L; Nakjang, S; Forster, V; Isa, A; Blair, HJ; Heidenreich, O: CCND2 is a RUNX1/ETO target required for leukaemic propagation
A11
Claviez, A; Brinkmeier, N; Zimmermann, M; Stanulla, M; Schrappe, M; Möricke, A: Prognostic Impact of Sex in Pediatric ALL in three consecutive ALL-BFM trials
A12
Raasch, S; Bronsema, A; Müller, J; Strauss, J; Eschenburg, M; Zur Stadt, U; Vater, I; Siebert, R; Horstmann, MA: FOXM1 haploinsufficiency in acute lymphoblastic leukemia
A13
Al-Kershi, S; Emmrich, S; Reimer, C; Heckl, D; Klusmann, JH: Stem cell-enriched long non-coding RNA HOXA10-AS contributes to the pathogenesis of MLL-rearranged AML
A14
Bhayadia, R; Jammal, R; Klusmann, JH: Members of the microRNA-193 family are potent tumor suppressors and independent biomarkers in acute myeloid leukemia
A15
Shi, Y; Heidenreich, O; van Delft, F; Krippner, A: An oncogenic role of LCK in T-cell Acute Lymphoblastic Leukaemia